Insider Transactions in Q2 2022 at Becton Dickinson & CO (BDX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2022
|
James C Lim Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
3,280
+12.05%
|
-
|
|
Jun 07
2022
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Open market or private sale
|
Direct |
443
-29.51%
|
$115,180
$260.0 P/Share
|
|
Jun 07
2022
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Sale (or disposition) back to the issuer
|
Direct |
583
-28.16%
|
$151,580
$260.0 P/Share
|
|
Jun 07
2022
|
Thomas J Spoerel SVPController & Chief Acct Off |
BUY
Exercise of conversion of derivative security
|
Direct |
1,026
+33.14%
|
$150,822
$147.68 P/Share
|
|
May 06
2022
|
David Hickey EVP & President, Life Sciences |
SELL
Open market or private sale
|
Direct |
475
-11.1%
|
$121,600
$256.0 P/Share
|
|
Apr 06
2022
|
Shana Carol Neal EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,525
+49.76%
|
-
|